
zzso two million zzso of zzso are administered in the UK every year, as part of zzso radical or zzso cancer zzso For many zzso types, zzso is routinely combined with zzso chemotherapy as part of zzso or radical zzso In addition, new agents have been developed in recent years and tested in phase 1, 2 and 3 trials zzso with zzso or zzso One such class of drugs, the zzso zzso zzso zzso has shown activity in conjunction with zzso in several cancer cell zzso zzso data suggest that zzso zzso may zzso the effects of zzso in several zzso types, namely zzso zzso head and neck, zzso zzso and prostate zzso In zzso zzso zzso are zzso in various cell lines with enhancement ratios of up to zzso In zzso zzso doses of zzso zzso have been shown to increase zzso growth delay of zzso zzso in zzso Clinical trials to assess the toxicity and potential benefit of combining zzso with zzso zzso are now zzso 

